Suggested Citation:"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2017. Global Health and the Future Role of the United States. Washington, DC: The National Academies Press. doi: 10.17226/24737.
×
Appendix C
Public Meeting Agendas
COMMITTEE MEETING ONE
September 29, 2016
Washington, DC
|
1:00–1:10 pm |
Welcoming Remarks |
| Jendayi Frazer, Co-Chair | |
| Valentin Fuster, Co-Chair | |
|
1:10–2:45 pm |
Sponsor Briefing: Discussion of the Committee’s Charge |
| Ariel Pablos-Méndez | |
| Assistant Administrator for Global Health, U.S. Agency for International Development | |
| Vikas Kapil | |
| Associate Director for Science and Chief Medical Officer, Center for Global Health, U.S. Centers for Disease Control and Prevention | |
| Leslie Ball | |
| Assistant Commissioner for International Programs, Office of International Programs, U.S. Food and Drug Administration |
Suggested Citation:"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2017. Global Health and the Future Role of the United States. Washington, DC: The National Academies Press. doi: 10.17226/24737.
×
| Roger Glass | |
| Director, Fogarty International Center, National Institutes of Health | |
| David Smith | |
| Deputy Assistant Secretary of Defense for Health Readiness Policy and Oversight, U.S. Department of Defense | |
| Summer Galloway | |
| Senior Policy Advisor, U.S. Department of Defense | |
| Christian Hassell | |
| Deputy Assistant Secretary of Defense for Chemical and Biological Defense Programs, U.S. Department of Defense | |
| Paurvi Bhatt (via teleconference) | |
| Senior Director for Global Access, Medtronic Philanthropy | |
|
2:45–3:15 pm |
Discussion with Committee |
|
3:15–3:30 pm |
Break |
|
3:30–4:15 pm |
Global Health and the United States—Past and Future Directions |
| Thomas Bollyky | |
| Senior Fellow for Global Health, Economics, and Development, Council on Foreign Relations | |
| Rebecca Katz | |
| Director, Center for Global Health Science and Security, Georgetown University | |
| Helene Gayle | |
| Cochair, CSIS Task Force on Women’s and Family Health; CEO, McKinsey Social Initiative | |
|
4:15–4:30 pm |
Discussion with Committee |
Suggested Citation:"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2017. Global Health and the Future Role of the United States. Washington, DC: The National Academies Press. doi: 10.17226/24737.
×
|
4:30–5:30 pm |
Public Comment Period |
| Any additional input/feedback from participants | |
|
5:30 pm |
Adjourn |
COMMITTEE MEETING TWO
December 6, 2016
Washington, DC
|
10:00–10:10 am |
Welcome and Introduction |
| Jendayi Frazer, Co-Chair | |
| Valentin Fuster, Co-Chair | |
|
10:10–11:00 am |
Overview and Programs: A Changing Landscape |
| Jimmy Kolker | |
| Assistant Secretary for Global Affairs, U.S. Department of Health and Human Services | |
| Chris Elias (via videoconference) | |
| President, Global Development Program, Bill & Melinda Gates Foundation | |
| Mark Dybul (via videoconference) | |
| Executive Director, Global Fund | |
| Loyce Pace | |
| Executive Director, Global Health Council | |
|
11:00 am–12:00 pm |
Discussion with Committee |
|
12:00–1:00 pm |
Lunch |
|
1:00–1:45 pm |
Future Financing Strategies for Global Health |
| Mariam Claeson | |
| Director, Global Financing Facility | |
| Natasha Bilimoria | |
| Director, U.S. Strategy, Gavi, the Vaccine Alliance |
Suggested Citation:"Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2017. Global Health and the Future Role of the United States. Washington, DC: The National Academies Press. doi: 10.17226/24737.
×
| Claire Qureshi | |
| Office of the United Nations Special Envoy for Health in Agenda 2030 and for Malaria; Interim Project Director, Financing Alliance for Health | |
|
1:45–2:45 pm |
Discussion with Committee |
|
2:45–3:00 pm |
Break |
|
3:00 pm |
Innovation to Build Capacity and Improve Health |
| Peter Singer (via videoconference) | |
| CEO, Grand Challenges Canada | |
| Kirsten Gagnaire | |
| Managing Director, Global Health and Digital Development, FSG | |
| Ed Seguine | |
| CEO, Clinical Ink | |
| Sarah Glass | |
| Director for Special Projects, U.S. Global Development Lab, U.S. Agency for International Development | |
|
4:00 pm |
Discussion with Committee |
|
5:00 pm |
Adjourn |
